CZECRIN was part of a professional conference organized by CEITEC—the Central European Institute of Technology —in collaboration with Prague.bio, with the goal of connecting key players from the academic, research, and private sectors and exploring opportunities for closer collaboration.
Prague.bio was founded in 2023 with the goal of fostering the biotechnology community in the Czech Republic and raising its profile not only domestically but also internationally. It brings together leading universities, research institutes, startups, and established companies, and emphasizes innovation and the effective transfer of research results into practical applications.
Representing MUNI | CREATIC, Dr. Jiri Deml gave a presentation in which he highlighted, among other things, the unique role of CZECRIN, which has become the National Infrastructure for Clinical Research.
We are part of the European ECRIN ERIC network, and thanks to a network of collaborating hospitals, specialized hubs, and experts, we provide comprehensive support for clinical trials in the Czech Republic.
What speaks for us:
🔹 300 requests for collaboration per year
🔹 More than 12,000 patients in clinical trials.
🔹 Expert support in the areas of regulations, pharmacovigilance, data analysis, and education.
